Nwam LLC Journey Medical Corp Transaction History
Nwam LLC
- $1.57 Billion
- Q4 2024
A detailed history of Nwam LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Nwam LLC holds 10,620 shares of DERM stock, worth $55,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,620
Previous 10,430
1.82%
Holding current value
$55,648
Previous $58,000
25.86%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DERM
# of Institutions
38Shares Held
2.88MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.73MShares$9.04 Million0.53% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.53 Million0.36% of portfolio
-
Cambridge Investment Research Advisors, Inc.328KShares$1.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny236KShares$1.24 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $60.8M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...